Virtual Reality in Functional Movement Disorder

NCT ID: NCT06393439

Last Updated: 2025-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-01

Study Completion Date

2026-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates the effect of virtual reality (VR) motor tasks on functional movement disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators want to investigate how different display modes of virtual hands and the experimental manipulation of the visual representation of virtual hand movements affect (1) the performance of the hand movements (2) the tremor and (3) the subjective perception of the tremor.

There are three groups: Patients with functional tremor (FT), patients with essential tremor (ET) and healthy controls (HC). The study is carried out on one or two consecutive days. The first appointment is only made for patients with ET and FT and is used for the neurological examination and to assess the severity of the tremor. It takes place at the Outpatient Clinic for Movement Disorders at the University Clinic for Neurology in Graz and lasts a maximum of 30 minutes. The second appointment is at the Institute of Psychology at the University of Graz and requires the active participation of the respondent for 2.5 hours. Subjects are asked not to take any tremor-influencing medication on the day of the examination. HC will only attend the appointment at the Institute of Psychology.

First appointment:

* Clinical Global Impression - Severity Scale (CGI-S): 5-point Likert scale, clinicians assess the severity of the condition
* Patient Global Impression of Severity (PGI-S): 5-point Likert scale, patients assess the severity of the condition
* Fahn Tolosa Marin Tremor Rating Scale (FTM): assesses the tremor severity
* Simplified Version of the Functional Movement Disorders Rating Scale (S-FMDRS): assesses the severity of the functional tremor

Second appointment:

1. Questionnaires:

* Simulator Sickness Questionnaire (SSQ): 4-point Likert scale, assesses nausea, oculomotor and visual disturbances, disorientation (2 timepoints: before and after VR tasks)
* Edinburgh Handedness Inventory (EDI)
* Questionnaire about sociodemographic data
* Technology Usage Inventory (TUI): 7-point Likert scale, acceptance and use of technologies
* Igroup Presence Questionnaire (IPQ): sense of presence in the VR
2. electroencephalogram (EEG) and surface-Electromyography (surface-EMG) of forearm muscles: run synchronously with the examinations
3. VR-tasks: all tasks are carried out in randomized order

1. 3x3 matrix: individual fields light up in random order, participants are instructed to touch the fields in the given sequence as quickly as possible. 30 repetitions with a realistic VR-hand model and 30 repetitions with an abstract VR-hand model.
2. 3x3 matrix: same task as (a) but after each repetition, participants must touch a field labeled "next" to continue the task. 30 repetitions.
3. apple in a box: a virtual apple is to be placed in a virtual box using the hand with the weaker tremor, while the other hand is left resting on the table. 30 repetitions.
4. apple in a box: same task as (c) but the resting hand is not visible. 30 repetitions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Functional Movement Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Functional Movement Disorder

Group Type EXPERIMENTAL

Virtual reality motor task

Intervention Type DIAGNOSTIC_TEST

After a short practice task, participants perform motor tasks in a virtual reality environment. Reaction time is used to assess task performance.

Essential Tremor

Group Type EXPERIMENTAL

Virtual reality motor task

Intervention Type DIAGNOSTIC_TEST

After a short practice task, participants perform motor tasks in a virtual reality environment. Reaction time is used to assess task performance.

Healthy Control

Group Type EXPERIMENTAL

Virtual reality motor task

Intervention Type DIAGNOSTIC_TEST

After a short practice task, participants perform motor tasks in a virtual reality environment. Reaction time is used to assess task performance.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual reality motor task

After a short practice task, participants perform motor tasks in a virtual reality environment. Reaction time is used to assess task performance.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosis of functional tremor (FT) or essential tremor (ET) or healthy control persons
* In patients with FT and ET: presence of a constant or intermittent tremor during the neurological examination

Exclusion Criteria

* unclear tremor syndrome
* essential tremor plus (ET plus)
* conditions that interfere with EEG diagnostic (skin conditions, skin infections, wounds)
* reflex epilepsy
* cervical degeneration or chronic pain syndrome of the cervical spine
* severe somatic illness
* previous cerebral or head surgery
* implanted pacemaker or deep brain stimulation
* persons who are unable to consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Graz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Petra Schwingenschuh, MD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Graz

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Graz, Department of Neurology

Graz, , Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Daniela Kern, MD

Role: CONTACT

004331638516051

Petra Schwingenschuh, MD

Role: CONTACT

004331638583379

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Daniela Kern, MD

Role: primary

+4331638516051

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36-115 ex 23/24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.